XtalPi Holdings Ltd
OTC:QNTPF

Watchlist Manager
XtalPi Holdings Ltd Logo
XtalPi Holdings Ltd
OTC:QNTPF
Watchlist
Price: 1.26 USD -3% Market Closed
Market Cap: 5.1B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one QNTPF stock under the Base Case scenario is 0.37 USD. Compared to the current market price of 1.26 USD, XtalPi Holdings Ltd is Overvalued by 70%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

QNTPF Relative Value
Base Case
0.37 USD
Overvaluation 70%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

52.9
P/S
P/S
Price to Sales
52.9
vs History
19
vs Industry
Median 3Y
29.2
Median 5Y
29.2
Industry
4
Forward
55.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-100.9
Median 5Y
-100.9
Industry
31.3
Forward
-60.1
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-86.2
Median 5Y
-86.2
Industry
20.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-121.5
Median 5Y
-121.5
Industry
33.2
More Details
5.2
P/B
P/B
Price to Book Value
5.2
vs History
19
vs Industry
Median 3Y
2.8
Median 5Y
2.8
Industry
2.8
More Details
45.2
EV/S
EV/S
Enterprise Value to Sales
45.2
vs History
19
vs Industry
Median 3Y
21.5
Median 5Y
21.5
Industry
3.9
Forward
47.4
More Details
70.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
70.8
vs History
19
vs Industry
Median 3Y
33.6
Median 5Y
33.6
Industry
8.8
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-44.3
Median 5Y
-44.3
Industry
18.5
Forward
-70
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-44.3
Median 5Y
-44.3
Industry
23
Forward
-77.6
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-73.7
Median 5Y
-73.7
Industry
19.6
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-63.8
Median 5Y
-63.8
Industry
24.8
More Details
12.9
EV/IC
EV/IC
Enterprise Value to IC
12.9
vs History
19
vs Industry
Median 3Y
6.1
Median 5Y
6.1
Industry
2.4
More Details

Multiples Across Competitors

QNTPF Competitors Multiples
XtalPi Holdings Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
XtalPi Holdings Ltd
OTC:QNTPF
5.1B USD 52.9 -183.1 -93.4 -93.4
US
PerkinElmer Inc
LSE:0KHE
959.3B USD 342.8 3 363.5 1 183.1 2 404.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
181B USD 4.2 27.5 21.1 26.4
US
Danaher Corp
NYSE:DHR
138.4B USD 5.8 40.5 21.3 32
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 14.1 55.3 31.1 43.5
CH
Lonza Group AG
SIX:LONN
38B CHF 5.4 51.8 37.8 37.8
CN
WuXi AppTec Co Ltd
SSE:603259
312.4B CNY 7.3 22.7 24.5 24.5
US
Agilent Technologies Inc
NYSE:A
35.9B USD 5.4 30.8 20.8 24.5
US
IQVIA Holdings Inc
NYSE:IQV
31.8B USD 2 25.7 12.9 19.4
US
Mettler-Toledo International Inc
NYSE:MTD
26.3B USD 6.8 31.7 23.1 25.6
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.1B EUR 6.2 80.3 27.4 47.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
XtalPi Holdings Ltd
OTC:QNTPF
Average EV/EBITDA: 140.3
Negative Multiple: -93.4 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 183.1
6%
197.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.1
5%
4.2
US
Danaher Corp
NYSE:DHR
21.3
7%
3
KR
Samsung Biologics Co Ltd
KRX:207940
31.1
17%
1.8
CH
Lonza Group AG
SIX:LONN
37.8
18%
2.1
CN
WuXi AppTec Co Ltd
SSE:603259
24.5
24%
1
US
Agilent Technologies Inc
NYSE:A
20.8
10%
2.1
US
IQVIA Holdings Inc
NYSE:IQV
12.9
8%
1.6
US
Mettler-Toledo International Inc
NYSE:MTD
23.1
4%
5.8
FR
Sartorius Stedim Biotech SA
PAR:DIM
27.4
20%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
XtalPi Holdings Ltd
OTC:QNTPF
Average EV/EBIT: 268.6
Negative Multiple: -93.4 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 404.9
30%
80.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
26.4
20%
1.3
US
Danaher Corp
NYSE:DHR
32
17%
1.9
KR
Samsung Biologics Co Ltd
KRX:207940
43.5
25%
1.7
CH
Lonza Group AG
SIX:LONN
37.8
22%
1.7
CN
WuXi AppTec Co Ltd
SSE:603259
24.5
19%
1.3
US
Agilent Technologies Inc
NYSE:A
24.5
15%
1.6
US
IQVIA Holdings Inc
NYSE:IQV
19.4
14%
1.4
US
Mettler-Toledo International Inc
NYSE:MTD
25.6
6%
4.3
FR
Sartorius Stedim Biotech SA
PAR:DIM
47.4
32%
1.5

See Also

Summary
QNTPF intrinsic value, competitors valuation, and company profile.
DCF Valuation
QNTPF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
QNTPF stock valuation using valuation multiples.
Wall Street Estimates
QNTPF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
QNTPF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 283,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.